AMRN: Amarin Corporation Company Current Liabilities

Amarin Corp (AMRN) - corporate logo

Amarin Corporation plc (AMRN) specializes in developing therapies for cardiovascular pathologies. This daily price chart illustrates the asset's performance, with a value of 0.00. The business implements software algorithms during drug development, although final trials require medical supervision. The company is currently experiencing stagnation due to the loss of exclusive rights to Vascepa, focusing its R&D on testing new compound combinations.

AMRN (Amarin) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Summary analytical data breakdowns for Amarin Pharma (AMRN)

- current quotes and average value forecast:
Price Chart Amarin|AMRN - Fair Value Consensus
- market capitalization information:
Market Valuation Amarin Corporation|AMRN - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Amarin|AMRN - Book Capitalization|Market Value to Book Value Ratio amarincorp.com|AMRN - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Amarin Corporation plc|AMRN - Long-Term Debt to Capital|Short-Term Debt to Equity Amarin Corporation plc|AMRN - Aggregate Debt Obligations|Debts to Book Capitalization Amarin Corporation|AMRN - Long-Term Debt Volume|Company Short-Term Debt Amarin|Quick Liquidity Indicator amarincorp.com
- net income and valuation multiples indicators:
AMRN - Final Profit
General company analysis:Amarin (AMRN)
Manufactured products of Amarin Corporation plc

This indicator measures total liabilities with maturities of up to twelve months, determining the business's liquid stability. By analyzing short-term financial borrowings, an investor assesses the default risk and the degree of dependence on external refinancing. For Amarin Corporation plc (AMRN), this is critical during the expansion of cardiovascular drugs in Europe. Minimal debt reduces vulnerability to generics in the US. A low debt load guarantees capital preservation.

Competitors of Amarin Corporation plc

REGN - Company Short-Term Debt|Company Short-Term Loans and Borrowings IRTC (iRhythm Technologies, Inc.)|LNTH (Lantheus Medical Imaging) - Company Current Liabilities|MLYS: Amount of Current Liabilities|HTFL (HeartFlow Inc) - Company Short-Term Debts|Company Short-Term Debts kestramedical.com|Company Short-Term Debt Esperion (ESPR)|Company Current Liabilities anteristech.com AVR|Company Short-Term Debts TNYA (Tenaya Therapeutics, Inc.)|Company Short-Term Debts CVRx Inc CVRX|MIST - Company Short-Term Debt|Company Short-Term Loans and Borrowings CRDL (Cardiol Therapeutics)|BEAT: Company Short-Term Debts|TENX - Short-Term Debt Volume|Company Short-Term Debt Adagio Medical Holdings Inc.|Company Short-Term Indebtedness BCDA (BioCardia Inc)|Company Current Liabilities VTAK (Catheter Precision)|ABIO (arcabio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ACST (Acasti Pharma Inc.)|AVTE - Company Current Liabilities|VERV - Company Short-Term Debt|Short-Term Debt Windtree Therapeutics